Dublin-based pharmaceutical group Shire on Tuesday said it has bid $30 billion (27 billion euros) for US rival Baxalta to form a global biotech company focused on rare diseases.
"We believe the proposed combination of Shire and Baxalta would be strategically and financially attractive for both of our companies, accelerating our respective growth ambitions and creating the leading global biotech company in rare diseases," Shire's Chief Executive Officer Flemming Ornskov said in a statement.
GMT 09:35 2017 Monday ,24 AprilGerman DAX stock market index hits new all-time high
GMT 08:13 2017 Monday ,24 AprilFirst large-scale malaria vaccine trials for Africa
GMT 08:11 2017 Monday ,24 AprilPentagon chief Mattis makes unannounced Afghan visit
GMT 07:29 2017 Monday ,24 AprilEuropean stocks surge at open on French vote result
GMT 07:27 2017 Monday ,24 AprilAfghan defence minister, army chief resign after Taliban attack
GMT 06:12 2017 Monday ,24 AprilPhilips posts first quarter jump in profits
GMT 06:10 2017 Monday ,24 AprilIn call with Trump, Xi urges 'restraint' on N. Korea
GMT 06:08 2017 Monday ,24 AprilTokyo shares up 1.4% as centrist Macron leads French presidential race